Preferencje help
Polish version English version Język
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 9

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych:  acute myeloid leukemia
help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
1

Two methods for the quantitative analysis of surface antigen expression in acute myeloid leukemia [AML]

100%
Wozniak J.
Folia Histochemica et Cytobiologica
|
2004
|
tom 42
|
nr 3
2

Acquired pericentric inversion of chromosome 9 in acute myeloid leukemia

86%
Udayakumar A. M., Pathare A. V., Dennison D., Raeburn J. A.
Journal of Applied Genetics
|
2009
|
tom 50
|
nr 1
73-76
Pericentric inversion of chromosome 9 involving the qh region is relatively common as a constitutional genetic aberration without any apparent phenotypic consequences. However, it has not been established as an acquired abnormality in cancer. Among the three patients reported so far in the literature with acquired inv(9), only one had acute myeloid leukemia (AML). Here we describe an unique case where both chromosomes 9 presented with an acquired pericentric inversion with breakpoints at 9p 13 and 9q 12 respectively, in a AML patient with aberrant CD7 and CD9 positivity. Additionally, one der(9) also showed short arm deletion at 9p21 to the centromeric region and including the p 16 gene. The constitutional karyotype was normal. This is probably the first report describing an acquired inv(9) involving both chromosomes 9 in AML. The possible significance of this inversion is discussed.
3

Prognostic significance of Ki67-negative blast cell clone in the high risk group of children treated for acute myeloid leukaemia

86%
Nowicki M., Ostalska-Nowicka D., Miskowiak B.
Folia Histochemica et Cytobiologica
|
2006
|
tom 44
|
nr 1
4

Effect of differentiating agents [all-trans retinoic acid and phorbol 12-myristate 13-acetate] on drug sensitivity of HL60 and NB4 cells in vitro

72%
Jasek E., Mirecka J., Litwin J. A.
Folia Histochemica et Cytobiologica
|
2008
|
tom 46
|
nr 3
323-330
5

Subcellular localization of full-length human myeloid leukemia factor 1 (MLF1) is independent of 14-3-3 proteins

72%
Molzan M., Ottmann C.
Cellular and Molecular Biology Letters
|
2013
|
tom 18
|
nr 1
Myeloid leukemia factor 1 (MLF1) is associated with the development of leukemic diseases such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). However, information on the physiological function of MLF1 is limited and mostly derived from studies identifying MLF1 interaction partners like CSN3, MLF1IP, MADM, Manp and the 14-3-3 proteins. The 14-3-3-binding site surrounding S34 is one of the only known functional features of the MLF1 sequence, along with one nuclear export sequence (NES) and two nuclear localization sequences (NLS). It was recently shown that the subcellular localization of mouse MLF1 is dependent on 14-3-3 proteins. Based on these findings, we investigated whether the subcellular localization of human MLF1 was also directly 14-3-3-dependent. Live cell imaging with GFP-fused human MLF1 was used to study the effects of mutations and deletions on its subcellular localization. Surprisingly, we found that the subcellular localization of full-length human MLF1 is 14-3-3-independent, and is probably regulated by other as-yet-unknown proteins.
6

Molecular diagnostics of promyelocytic leukaemia

72%
Kocki J., Constantinou M., Cioch M., Lancut M., Kaluzewski B., Dmoszynska A., Wojcierowski J.
Journal of Applied Genetics
|
2003
|
tom 44
|
nr 4
7

The transcription factor PU.1 is a critical regulator of cellular communication in the immune system

58%
Turkistany S. A., DeKoter R. P.
Archivum Immunologiae et Therapiae Experimentalis
|
2011
|
tom 59
|
nr 6
8

Interferon production by peripheral blood leukocytes of patients with acute myeloid leukemia

58%
Kandefer-Szerszen M., Dmoszynska A., Borowska L., Adamczyk-Cioch M., Hus M., Hus I., Rolinski J.
Archivum Immunologiae et Therapiae Experimentalis
|
1996
|
tom 44
|
nr 2-3
9

The interaction of daunorubicin and mitoxantrone with the red blood cells of acute myeloid leukemia patients

58%
Marczak A., Wrzesien-Kus A., Krykowski E., Robak T., Jozwiak Z.
Cellular and Molecular Biology Letters
|
2003
|
tom 08
|
nr 4
The effect of DNR and MIT on erythrocyte membrane structure was examined using Electron Spin Resonance spectroscopy and the fluorimetric technique. The results suggest that the in vivo interaction of the drugs with the RBCs of AML patients led to a perturbation in the structure of plasma membrane components. Differences between DNR and MIT were only noted in the interaction of the drugs with deeper regions of the lipid bilayer.
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.